# Adiponectin in Obese Women With T2DN and Effects by RAS Blocker

> **NCT00561704** · NA · COMPLETED · sponsor: **Shanghai Jiao Tong University School of Medicine** · enrollment: 80 (actual)

## Conditions studied

- Obese
- Type 2 Diabetes
- Diabetic Nephropathy
- Glucose Metabolism
- Angiotensin II Type 1 Receptor Blockers

## Interventions

- **DRUG:** losartan

## Key facts

- **NCT ID:** NCT00561704
- **Lead sponsor:** Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2007-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00561704

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00561704, "Adiponectin in Obese Women With T2DN and Effects by RAS Blocker". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT00561704. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*